IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.114
NA - Nord America 1.282
EU - Europa 628
SA - Sud America 225
AF - Africa 39
OC - Oceania 4
Totale 7.292
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 4.087
US - Stati Uniti d'America 1.218
CN - Cina 522
IT - Italia 300
HK - Hong Kong 241
BR - Brasile 161
VN - Vietnam 108
FR - Francia 83
GB - Regno Unito 66
DE - Germania 43
MX - Messico 37
IN - India 36
NL - Olanda 31
AR - Argentina 24
ID - Indonesia 19
CA - Canada 18
FI - Finlandia 16
CZ - Repubblica Ceca 15
PL - Polonia 15
ZA - Sudafrica 15
BD - Bangladesh 14
EC - Ecuador 12
UA - Ucraina 12
TR - Turchia 11
CL - Cile 9
PK - Pakistan 9
RU - Federazione Russa 8
SA - Arabia Saudita 8
ES - Italia 7
MY - Malesia 7
JP - Giappone 6
PH - Filippine 6
SE - Svezia 6
UY - Uruguay 6
CH - Svizzera 5
KE - Kenya 5
PY - Paraguay 5
AT - Austria 4
AZ - Azerbaigian 4
BY - Bielorussia 4
IQ - Iraq 4
LB - Libano 4
AU - Australia 3
BE - Belgio 3
BH - Bahrain 3
CO - Colombia 3
HU - Ungheria 3
JM - Giamaica 3
PE - Perù 3
AO - Angola 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
IE - Irlanda 2
IL - Israele 2
JO - Giordania 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
NP - Nepal 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BJ - Benin 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
IS - Islanda 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
SO - Somalia 1
TH - Thailandia 1
TL - Timor Orientale 1
TW - Taiwan 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 7.292
Salva come PNG Salva come JPEG
Città #
San Jose 453
Singapore 368
Ashburn 276
Rome 247
Hong Kong 235
Hefei 160
Beijing 147
Lauterbourg 73
Dallas 72
Shanghai 69
Boardman 61
Ho Chi Minh City 41
London 38
Mexico City 26
Los Angeles 23
New York 23
Santa Clara 23
Hanoi 22
São Paulo 20
Amsterdam 17
Munich 17
San Francisco 16
Brno 15
Council Bluffs 14
Seattle 12
Turku 12
Warsaw 12
Orem 11
Boston 10
Toronto 10
Chennai 8
Haiphong 8
Manchester 8
Pune 8
Guangzhou 7
Johannesburg 7
Rio de Janeiro 7
Atlanta 6
Brooklyn 6
Da Nang 6
Guayaquil 6
Frankfurt am Main 5
Lahore 5
Tokyo 5
Brasília 4
Helsinki 4
Kuala Lumpur 4
Montevideo 4
Montreal 4
Nairobi 4
New Delhi 4
Paris 4
Stockholm 4
Washington 4
Baku 3
Brownsville 3
Buffalo 3
Canberra 3
Charlotte 3
Chicago 3
City of London 3
Denver 3
Helena 3
Krasnodar 3
Manama 3
Manaus 3
Medellín 3
Minsk 3
Poplar 3
Ribeirão Preto 3
Riyadh 3
Thái Nguyên 3
Vienna 3
Zurich 3
Arayat 2
Bari 2
Bekasi 2
Belo Horizonte 2
Belém 2
Bình Dương 2
Camden 2
Campinas 2
Cape Town 2
Central 2
Changchun 2
Cuauhtémoc 2
Curitiba 2
Embu das Artes 2
Goiânia 2
Gothenburg 2
Ha Long 2
Hải Dương 2
Islamabad 2
Istanbul 2
Jackson 2
Jaipur 2
Jakarta 2
Jaú 2
José C. Paz 2
Kharkiv 2
Totale 2.767
Salva come PNG Salva come JPEG
Nome #
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 244
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 225
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 223
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 222
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 221
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 213
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 213
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 207
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 206
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 204
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 199
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 196
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 194
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 191
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 190
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 189
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 129
A challenging alfa-fetoprotein in a cirrhotic patient 126
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 118
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 113
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 113
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 111
ALT levels are associated with metabolic parameters and age in a large real-life population. 109
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 108
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 107
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 105
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 101
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 97
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 94
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 90
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 87
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 80
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 76
Sarcopenia in Chronic Liver Disease: The Emerging Role of Ultrasound in Determining Muscle Mass, Strength and Clinical Outcomes 75
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 73
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 73
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 73
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 66
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 64
Pain and Frailty in Hospitalized Older Adults 63
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 59
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 58
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 56
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 54
What changed in the Italian internal medicine and geriatric wards during the lockdown 53
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 52
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 51
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 50
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 49
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 48
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 47
Individuation of presence and combination of genetic risk factors may help to refine the risk for most severe forms of NAFLD 47
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 46
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 46
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 46
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 46
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 44
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 44
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 44
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 43
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 42
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 41
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 41
Decoding the molecular and genomic landscape of hepatocellular carcinoma: biomarker discovery, classification frameworks, and therapeutic targeting 40
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 40
Renal impairment and anemia during triple therapy 40
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 40
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 38
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 38
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 38
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 36
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 36
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 34
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 34
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 34
Steroid-refractory immune related hepatitis may hide viral re-activation 33
Liver Cirrhosis is Characterized by an Acquired Lysosomal Acid Lipase Deficiency Independent from the Etiology of Liver Disease 33
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 32
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 30
Prevalence of patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 C/G polymorphism in patients with bona-fide post-NASH cirrhosis 30
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 28
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 21
Totale 7.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.726
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202290 0 0 2 0 1 0 2 2 12 0 2 69
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024176 6 14 4 23 13 78 2 6 3 6 5 16
2024/20254.457 38 16 66 12 129 98 77 14 176 263 1.749 1.819
2025/20262.608 243 156 192 300 135 156 779 165 216 266 0 0
Totale 7.350